PRACTICES

To maximize the protection of your legitimate rights and interests
JINCHENG TONGDA & NEAL
CAPITAL MARKETS AND IPO
OVERVIEW

As one of the first law firms qualified to engage in securities legal business, JT&N has helped numerous enterprises go public smoothly both domestically and internationally and successfully issue stocks. JT&N has participated in and witnessed many groundbreaking and epoch-making IPO projects, and contributed numerous innovative solutions for complex projects. Over the past thirty years, JT&N has assisted listed companies globally, with businesses involving major stock exchanges including Shanghai, Shenzhen, Beijing, Hong Kong, Singapore, New York, and NASDAQ.

SERVICE

  • Legal Due Diligence and Rectification

  • System Reform Plan

  • Listing Guidance and Regulatory Governance

  • Listing Declaration and Feedback Response

  • Legal Opinions and Feedback During Registration and Issuance Stages

DEALS

  • CAMCE (002051, one of the first small and medium-sized enterprise boards, the first IPO stock in the fully circulated market environment after the "resumption of share sales")

  • Dinghan Technology (300011, one of the first listed companies on the GEM)

  • Chengdu Gas (603053, the first listed company with a trade union as the initiator and over 200 shareholders applying for an initial public offering with administrative permission)

  • JPT (688025, the first stock on the Science and Technology Innovation Board for industrial lasers)

  • Micro-tech (Nanjing) (688029, the first company in Nanjing to list on the Science and Technology Innovation Board)

  • Nanhua Futures (603093, the first futures company listed on the A-share market)

  • Tianjin Yiyi (001206, the first pet products stock in the A-share market)

  • Dahongli (300865, one of the first projects listed under the registration system of the GEM)

  • China National Electric Apparatus Research Institute (688128, the first state-owned research institute transformed company listed on the Science and Technology Innovation Board)

  • Ascentage Pharma (06855.HK, the "First Original Small Molecule New Drug Stock" of the Hong Kong stocks)


RELATED PRACTICE AREAS
LAWYER SEARCH